https://clinicaltrials.gov/ct2/show/NCT02896868?type=Intr&cond=Psoriasis&lupd_s=03%2F20%2F2019&lupd_d=14
Conditions : Skin Diseases; Psoriasis
Interventions : Drug: LY3041658; Drug: Placebo
Sponsor : Eli Lilly and Company
Active, not recruiting
A Study of LY3041658 in Participants With Skin Diseases
NCT02896868
Mon, 12 Sep 2016 12:00:00 EDT
Last Update Posted: 04/03/19 07:43AM